Pre-clinical safety evaluation of ceftazidime.
Toxicology Department, Glaxo Group Research Ltd., Ware, England.
K
K
Capel-Edwards
C R
CR
Losty
M L
ML
Tucker
D A
DA
Pratt
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000633:toxicity*; D002442:Ceftazidime / Q000008:administration & dosage / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006168:Guinea Pigs; D007928:Lethal Dose 50; D009152:Mutagenicity Tests; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D013723:Teratogens / Q000633:toxicity
D000900:Anti-Bacterial Agents; D013723:Teratogens; D002442:Ceftazidime